Skip to content

Self-monitoring Focus Groups With Vibrant Lives Pasadena Participants

Self-Monitoring Focus Groups With Vibrant Lives Pasadena Participants

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04611087
Enrollment
39
Registered
2020-11-02
Start date
2018-07-03
Completion date
2027-04-30
Last updated
2026-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity-Related Malignant Neoplasm

Brief summary

This study investigates how individuals feel about a dietary mobile application. Information collected from focus groups and interviews may help doctors and mobile application developers to determine preferences and participant feedback about the appeal and usefulness of a mobile application.

Detailed description

PRIMARY OBJECTIVE: I. To gather qualitative data to assess appeal, preference, and usefulness of a food and beverage self-monitoring mobile application. OUTLINE: PHASE I: Participants attend 4 sessions of focus groups. PHASE II: Participants attend virtual Zoom interviews or one-on-one interviews.

Interventions

BEHAVIORALDiscussion

Attend focus groups

OTHERInterview

Attend interviews

OTHERSurvey Administration

Ancillary studies

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Pasadena Independent School District (ISD) employees who have completed the 6-month Vibrant Lives weight loss program or adults who have completed a weight loss program within the last 12 months

Design outcomes

Primary

MeasureTime frameDescription
Preferences of food and beverage self-monitoring methodology and respective feedback messagesUp to 3 yearsThematic and narrative analyses will be conducted from the transcriptions to gain an understanding for the preferences of food and beverage self-monitoring methodology and respective feedback messages.

Countries

United States

Contacts

CONTACTKaren M Basen-Engquist
kbasenen@mdanderson.org713-745-3123
PRINCIPAL_INVESTIGATORKaren M Basen-Engquist

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 12, 2026